Background and Purpose-Although subcortical vascular dementia, the major subtype of vascular dementia, is caused by a disruption in white matter integrity after cerebrovascular insufficiency, no therapy has been discovered that will restore cerebral perfusion or functional cerebral vessels. Because adrenomedullin (AM) has been shown to be angiogenic and vasoprotective, the purpose of the study was to investigate whether AM may be used as a putative treatment for subcortical vascular dementia. Methods-A model of subcortical vascular dementia was reproduced in mice by placing microcoils bilaterally on the common carotid arteries. Using mice overexpressing circulating AM, we assessed the effect of AM on cerebral perfusion, cerebral angioarchitecture, oxidative stress, white matter change, cognitive function, and brain levels of cAMP, vascular endothelial growth factor, and basic fibroblast growth factor. Results-After bilateral common carotid artery stenosis, mice overexpressing circulating AM showed significantly faster cerebral perfusion recovery due to substantial growth of the capillaries, the circle of Willis, and the leptomeningeal anastomoses and reduced oxidative damage in vascular endothelial cells compared with wild-type mice. Vascular changes were preceded by upregulation of cAMP, vascular endothelial growth factor, and basic fibroblast growth factor. White matter damage and working memory deficits induced by bilateral common carotid artery stenosis were subsequently restored in mice overexpressing circulating AM. Conclusions-These data indicate that AM promotes arteriogenesis and angiogenesis, inhibits oxidative stress, preserves white matter integrity, and prevents cognitive decline after chronic cerebral hypoperfusion. Thus, AM may serve as a strategy to tackle subcortical vascular dementia. (Stroke. 2011;42:1122-1128.)
values but thereafter began to recover in all groups. On Days 1 and 3 post-BCAS, there was a slight, but not significant, increase in CBF (averageϮSEM) in mice overexpressing circulating AM (AM-Tg) compared with wild-type (WT) mice. On Day 7 post-BCAS, AM-Tg mice showed significantly faster CBF recovery: CBF was significantly higher in AM-Tg mice (93%Ϯ2%) compared with WT mice (79%Ϯ2%) and hydralazine-treated WT mice (71%Ϯ2%; Figure 1A -C). This trend continued on Days 14 and 28 post-BCAS ( Figure 1C ; Supplemental Figure IA ). Slower CBF recovery in hydralazine-treated WT mice suggests that AM-induced CBF recovery may not be associated with the hypotensive effect of AM.
We further examined the effects of postoperative exogenous infusion of AM. 6, 7 Continuous intraperitoneal injection of recombinant human AM at a rate of 50 ng/hr for 2 weeks, beginning on Day 1 post-BCAS, resulted in a significantly faster CBF recovery compared with the vehicle-treated mice ( Figure 1D ). These effects were comparable to those seen in BCAS-operated AM-Tg mice.
Thus, both genetically overproduced AM and postoperative exogenous administration of AM facilitated recovery of CBF after BCAS.
Adrenomedullin Enhances Arteriogenesis After BCAS
At the dorsal surface of the brain, a significant increase in diameter of the leptomeningeal anastomoses was found in AM-Tg mice (28.7Ϯ1.6 m) compared with WT mice To evaluate monocyte recruitments and proliferation of smooth muscle cells, both of which are essential in arteriogenesis, the immunofluorescent analysis of Ki-67 and F4/80, together with ␣-smooth muscle actin, was performed. BCASoperated AM-Tg mice showed a significant increase in Ki-67-positive vascular smooth muscle cells compared with BCAS-operated WT mice (Supplemental Figure IC) . In addition, a significant increase in vascular smooth muscle cells surrounded by F4/80-positive monocyte/macrophages was found in BCAS-operated AM-Tg mice compared with sham-operated WT mice (Supplemental Figure ID) .
Adrenomedullin Enhances Angiogenesis After BCAS
A significant increase in platelet-endothelial cell adhesion molecule-1-positive capillary density of the cortex, corpus cal- Taken together, these results suggest that both chronic ischemic stress and AM overexpression are required to induce arteriogenesis and angiogenesis in the brain.
Adrenomedullin Attenuates Oxidative Damage in Cerebral Microvessels After BCAS
To evaluate oxidative damage in cerebral microvessels, double immunofluorescence staining for platelet-endothelial cell adhesion molecule-1 and 8-hydroxy-deoxyguanosine was performed on Day 3 post-BCAS. A significant decrease in oxidative damage in the cerebral microvessels was found in BCAS-operated AM-Tg mice compared with BCAS-operated WT mice ( Figure 3D ; Supplemental Figure IF ).
Adrenomedullin Preserves WM Integrity After BCAS
BCAS-operated WT mice showed an increased density of glial fibrillary acidic protein-positive astrocytes and ionized calcium binding adapter molecule 1-positive microglia and a decreased density of glutathione-S-transferase-pi-immunoreactive mature oligodendrocytes in the corpus callosum and the anterior commissure compared with sham-operated WT or AM-Tg Klüver-Barrera staining on Day 28 revealed that BCASinduced WM lesions were predominant in the corpus callosum and the caudoputamen in WT mice (Supplemental Figure IIA, m-o) . In AM-Tg mice, such WM lesions became far less severe (Supplemental Figure IIAp) . In the hydralazine-treated WT mice, BCAS-induced WM lesions were as severe as those in WT mice, suggesting that such positive effects of AM may be independent of the hypotensive effect of AM ( Figure 4D ).
Thus, BCAS-induced WM lesions were restored in the AM-Tg mice in parallel with inhibition of glial activation and preservation of mature oligodendrocytes.
Adrenomedullin Prevents Working Memory Deficits After BCAS
To evaluate working memory, we examined a Y maze test and an 8-arm radial maze test. The Y maze test was performed 1 month after the surgery. Alternations of entries in the arms of the Y maze were significantly increased in BCAS-operated AM-Tg mice (64.6%Ϯ7.5%) compared with BCAS-operated WT mice (58.2%Ϯ8.0%), although alternations of entries were not significantly different between WT and AM-Tg mice after sham operation ( Figure 5A ). Spontaneous activity was not significantly different among the 4 groups of mice ( Figure 5B ). In another set of mice, the 8-arm radial maze test was started 1 month after BCAS. BCASoperated AM-Tg mice showed a significant reduction in the number of revisiting errors compared with BCAS-operated WT mice ( Figure 5C ). We have found a significant correlation of the averaged number of revisiting errors 1 month after BCAS with CBF on Days 7, 14, and 28, but not with CBF immediately after BCAS, or on Days 1 and 3 (Supplemental Figure III) .
Taken together, these results suggest that AM restores working memory deficits induced by BCAS.
Adrenomedullin Increases cAMP Level in the Forebrain After BCAS
The restorative effect of AM described led to the investigation of the underlying mechanisms behind angio-/arteriogenesis and antioxidative activity. The brain level of cAMP, a second messenger known to associate with AM, was therefore measured. A significant increase in the brain level of cAMP was found in AM-Tg mice after BCAS (AM BCAS, 1.6Ϯ0.2 pmol/mg wet tissue) compared with WT mice after BCAS (WT BCAS, 1.3Ϯ0.2 pmol/mg wet tissue) on Day 5, although the level of cAMP was not different between WT and AM-Tg mice after sham operation ( Figure 6A ).
These results suggest that chronic ischemic stress induced AM-mediated elevation of cAMP in the brain.
Adrenomedullin Increases mRNA and Protein Levels of Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor in the Forebrain After BCAS
The reasons behind the apparent AM-initiated signaling pathway-led arteriogenesis and angiogenesis were next examined. Brain levels of vascular growth factors, including vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), were therefore measured. 
Chronic Ischemic Insult Upregulates Brain mRNA Level of Adrenomedullin and Abolishes Receptor Activity-Modifying Protein-2 Suppression Induced by Adrenomedullin
The status of mouse AM, high-affinity AM receptors, calcitonin receptor-like receptors, and Subtypes 2 and 3 of a family of receptor activity-modifying proteins (RAMP2 or 3) were then measured on Day 5. The brain mRNA level of mouse AM was significantly increased (3.1-fold) in BCASoperated WT mice compared with sham-operated WT mice. In addition, brain RAMP2 mRNA level was significantly lower (0.6-fold) in sham-operated AM-Tg mice compared with shamoperated WT mice. Such downregulation of RAMP2 mRNA was abolished after the AM mice were subjected to BCAS operation, suggesting that feedback inhibition is a plausible cause for the downregulation ( Figure 6D ).
Discussion
Three major conclusions may be drawn from the present study. First, it was demonstrated that increased levels of circulating AM restored cerebral hemodynamics, promoted arteriogenesis as well as angiogenesis, alleviated oxidative damage in the cerebral microvessels, and preserved WM integrity; this subsequently attenuated working memory deficits in a mouse model of chronic cerebral hypoperfusion. Second, AM selectively upregulated brain levels of cAMP, VEGF, and bFGF in the hypoperfused brain but not in the normoperfused brain. Finally, it was found that such proangiogenic/arteriogenic changes did not occur in sham-operated AM-Tg mice in which the expression of AM receptor component RAMP2 was significantly suppressed, possibly through feedback inhibition.
We have found a significant correlation in the averaged number of revisiting errors at 1 month after BCAS with CBF on Days 7, 14, and 28, but not with CBF immediately after BCAS or on Days 1 and 3. Therefore, the recovery of CBF is one of the substrates for the functional improvements, whereas several phenomena other than CBF recovery may play roles in the pathophysiology of this BCAS model. In fact, we demonstrated that AM induced not only CBF recovery as a result of arteriogenesis, but also angiogenesis (not associated with CBF recovery), antioxidative activity in the microvessels, and attenuation of microglial inflammatory responses. The other effects of AM, including antiapoptotic effects and regulation of endothelial permeability or the blood-brain barrier, 3 need further investigation. Positive effects of AM may be mediated by multiple pathways.
Previous reports showed that the AM/cAMP/PKA cascade blocks oxidative damage in ischemic injury 8 and promotes angiogenic effects of the endothelial cells in vitro. 9 We found that chronic ischemic insult and circulating AM are both required to raise cAMP levels in the brain; this may be associated with alleviating oxidative damage and promoting angiogenesis.
The elevation of VEGF is consistent with the previous report that AM administration upregulates the expression of VEGF in both in vitro and in vivo hindlimb ischemia models. 6 Although no previous studies have reported that AM enhances the expression of bFGF after ischemia, we demonstrated the AM-induced upregulation of bFGF after BCAS in vivo. AM was also found to upregulate bFGF as well as VEGF in the cultured endothelial cells (unpublished data). Previous reports have demonstrated that combined gene delivery of VEGF and bFGF produces additive or synergistic effects on angiogenesis or collateral development, probably due to the protective effects of bFGF against VEGF-induced fluid leakage. 10 Thus, AM-induced elevation of bFGF may be associated with the development of functional vessels.
AM acts through 2 subtypes of receptor (AM1 and AM2), which derive from the interaction of the calcitonin receptorlike receptors with RAMP2 or 3. 11 Interestingly, RAMP2 mRNA level in sham-operated AM-Tg mice was significantly decreased compared with sham-operated WT mice but nearly reached normalization after BCAS. This may explain why arteriogenesis and angiogenesis were significantly promoted in AM-Tg mice only after ischemic insult. Shindo et al have reported that RAMP2 rather than RAMP3 is a key determinant of the effects of AM on the vasculature and is essential for angiogenesis and vascular integrity. 11 These results suggest that the AM-initiated signaling pathway is suppressed by downregulation of RAMP2 in the normoperfused brain but that such suppression is abolished by chronic ischemic stress, leading to AM-induced arteriogenesis and angiogenesis. Such tissue selectivity could be an advantage for clinical application of AM in patients with subcortical vascular dementia.
Recently, the concept of an "oligovascular niche" has been proposed, in which crosstalk between endothelial cells and oligodendrocytes, mediated by an exchange of soluble signals such as fibroblast growth factor, are thought to play an important role in sustaining oligodendrocyte homeostasis and WM integrity. 12 Because cerebral endothelial cells contribute to numerous signaling cascades that help regulate brain homeostasis and function, 13 angio-/arteriogenesis and inhibition of oxidative damage in the cerebral endothelial cells induced by AM might lead to oligovascular protectionnamely, successful vascular growth and vasoprotection and preservation of white matter/oligodendrocyte integrity-and prevention of cognitive decline after chronic cerebral hypoperfusion in mice.
In conclusion, this study demonstrates that circulating AM is a highly potent and effective modality for restoring perfusion, promoting arteriogenesis and angiogenesis in the chronically ischemic brain, inhibiting oxidative damage in the cerebral microvessels, preserving ischemic WM integrity, and attenuating working memory deficits in a mouse model of subcortical vascular dementia. Future clinical studies are required to evaluate and confirm the efficacy of AM in chronic cerebral vascular diseases, especially subcortical vascular dementia.
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Supplemental Methods
Mice
A generation of transgenic mice overexpressing human adrenomedullin (AM-Tg mice) has been described in a previous study. 1 Because the product is secreted from the liver, it mimics intravenous administration of the agent. and mature PAMP, respectively. To identify the specific effects of AM, we generated a transgene construct with a point mutation on the PAMP amidation signal in the full-length AM gene cDNA.
Guanine was substituted for cytosine on the 3' end of the PAMP coding region so that glycine on the C terminal of the PAMP product was replaced with alanine. In this way, amidation and maturation of PAMP by peptidylglycine α-hydroxylase and α-hydroxyglycine N-C lyase were inhibited. The mutant AM gene cDNA was then inserted into a plasmid containing the human serum amyloid P component promoter, which is widely used to target gene expression specific to the liver. When the product is secreted from the liver, it mimics intravenous administration of the agent. The HindIII-XhoI fragment of the plasmid was microinjected into the pronucleus of fertilized C57BL/6J mice eggs. Comparisons were then performed between AM-Tg mice and wild-type (WT) littermates. Plasma concentrations of human total AM were measured with a commercially available immunoradiometric assay (Shionogi).
Blood pressure (BP) was measured by the tail cuff method (Softron). The mice were housed in a room with a 12-hour light/dark cycle (lights on at 7:00 a.m.) with access to food and water ad libitum.
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Induction of chronic cerebral hypoperfusion
Adult C57BL/6J male mice (10-12 weeks old, 22-29 g; Shizuoka Laboratory Animal Center) were subjected to bilateral common carotid artery stenosis (BCAS) using microcoils with an internal diameter of 0.18 mm, as previously described. [2] [3] [4] Sham-operated mice underwent the same surgical procedure without using microcoils. Anesthesia was induced with 4% halothane and maintained with 1.5% halothane in 80% nitrous oxide and 20% oxygen. Rectal temperature was maintained between 36.5°C and 37.5°C.
Exogenous administration of hydralazine
To evaluate the possibility that the lower BP observed in AM-Tg mice caused beneficial effects on BCAS, we further analyzed BP-matched mice by administration of low-dose hydralazine (0.1 mmol/L) in drinking water. 
Exogenous administration of AM
Recombinant human mature AM dissolved in 0.9% saline was exogenously administrated to C57BL/6J WT mice by means of osmotic pumps (Alzet Model 1002) as previously described. 1, 5 The AM groups received a continuous intraperitoneal injection of recombinant human AM at a rate of 50 ng/h for 2 weeks beginning on day 1 post-BCAS. The vehicle groups received 0.9% saline only.
Measurement of cerebral blood flow
The flow were monitored by the use of a laser speckle blood flow imaging system (Omegazone, Omegawave), as previously reported, but with some modifications. 6, 7 In the day prior to the first day of CBF measurement anesthesia was induced with 4% halothane and maintained with 1.5% halothane in 80% nitrous oxide and 20% oxygen, the skull was exposed by a midline scalp incision 
Visualization of cerebral angioarchitecture
The cerebral angioarchitecture was studied by a modification of the postmortem latex perfusion technique on day 7 after the surgery. [9] [10] [11] [12] [13] [14] The root of the ascending aorta was cannulated with flexible S4 plastic tubing (0.65 mm external diameter). The tubing was connected to a 5 mL syringe, the cannulated aorta, and a mercury manometer, establishing a closed circuit to monitor perfusion pressure. A lethal dose of papaverine hydrochloride (40 to 50 mg/kg) was injected to produce maximal vasodilation. Immediately after 2 mL saline injection, 4 mL white latex compound (Chicago Latex Products) mixed with 50 µL/mL carbon black (Fueki) diluted 2:1 with saline was injected at a perfusion pressure of 150 mm Hg over a 5-minute period. After the initiation of infusion, the right atrium of the heart was incised to allow for venous outflow. The injected volume of latex, as well as the time taken to harden the latex sufficiently, was much greater than those of previous reports (0.4-2 mL, 2 minutes). 9, 10, 13 In order to harden the latex completely for the brain removal procedure, the dead animal was soaked in ice-cold water 20 minutes after the end of infusion, and the brain was 
S5
Histologic and immunohistochemical evaluation
Mice were euthanized 7 and 28 days after the surgery. The harvested brains were subjected to histologic examination using a standard procedure described elsewhere. 2 Klüver-Barrera (KB) staining was used to observe any histological changes. The severity of the white matter (WM) lesions was semiquantitatively graded into four levels by an investigator blind to the experimental condition. . Vessels with a diameter between 3 and 8 μm were counted. The vessel counts were performed in ten fields in the cerebral cortex, the corpus callosum, and the caudoputamen of the coronally-cut sections at 0 to 0.5 mm anterior from the bregma.
Analysis of oxidative damage in cerebral vessels
To evaluate oxidative damage in cerebral microvessels, double immunofluorescence staining for PECAM-1 and 8-OHdG was performed on day 3 post-BCAS. The acquired images were processed using Adobe Photoshop (version 7, Adobe System). RGB images were converted to 8-bit grayscale images. Based on an analysis of pixel fluorescence intensities, which ranged from 0 to 255, specific staining was distinguished from background by using a threshold value of 45-50 for 8-OHdG and 
Y maze test
The Y maze test was performed at 1 month after the surgery in a manner similar to that described previously. 16 The Y maze is a three-arm maze with equal angles between all arms that is used to evaluate working memory. Mice were initially placed within one arm and allowed to move in the maze freely. The sequence and number of arm entries were recorded for each mouse over an 8-minute period. The percentage of triads in which all three arms were represented (ABC, CAB, or BCA but not BAB) was recorded as an alternation to estimate short-term memory of the last arms entered. The total number of possible alternations is the number of arm entries minus two. Furthermore, the number of arm entries serves as an indicator of spontaneous activity.
Eight-arm radial maze test
The 8-arm radial maze test was started at 1 month after BCAS. The test was conducted in a manner similar to that described previously. 17 Each arm (8×35 cm) radiated from an octagonal central starting platform (perimeter 10×8 cm). Identical food wells were used (1 cm deep and 2.1 cm in diameter).
One week before pretraining, animals were deprived of food until their body weight was reduced to 75-85% of the initial level. Pretraining started on the eighth day. Each mouse was placed in the central starting platform and allowed to explore and to consume food pellets scattered on the whole maze for a 5-minute period (one session per mouse). After completion of the initial pretraining, mice received another pretraining to take a pellet from each food well after being placed at the distal end of each arm.
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A trial was finished after the subject consumed the pellet. This was repeated eight times, using eight different arms, for each mouse. After these pretraining trials, actual maze acquisition trials were performed. All eight arms were baited with food pellets. Mice were placed on the central platform and allowed to obtain all eight pellets within 25 minutes. A trial was terminated immediately after all eight pellets were consumed or 25 minutes had elapsed. An "arm visit" was defined as traveling for >5 cm from the central platform.
cAMP assay cAMP levels in the forebrain were determined by the radioimmunoassay method as previously described. 18 Mice were euthanized 5 days after surgery, the brain removed and frozen with liquid nitrogen, then preserved at -80°C. About 100 mg of frozen forebrain tissue was homogenized and extracted twice with 1 mL of ice-cold 0.1 N HCl solution. After centrifugation at 3000 rpm for 15 minutes at 4°C, the amounts of cAMP in the mixed supernatant was determined by radioimmunoassay using Yamasa cAMP assay kits (Yamasa).
Analysis of VEGF and bFGF protein expression in the forebrain
Western blot analysis of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) was performed using protein extracts from the forebrain tissue of sham-and BCAS-operated mice on days 1 and 5. Forebrain tissue was homogenized in RIPA buffer (1X PBS, 1% Igepal, 0.5% sodium deoxycholate and 0.1% SDS with protease and phosphatase inhibitors (Sigma)) Homogenates were centrifuged at 10,000 x g for 15 minutes at 4°C to remove insoluble proteins and fibrous tissue, and protein content for each sample was determined using bicinchoninic acid (BCA protein assay;
Pierce-Rockford). Samples were separated by SDS-PAGE on 10% gels then transferred to PVDF membranes. Membranes were blocked in 5% non-fat dry milk for 30 minutes at room temperature 
Statistical analysis
All values are expressed as means ± SD, unless stated otherwise. Group differences for hemodynamic, morphological, and general physiological measurements were analyzed for statistical significance by Student's t test or ANOVA. Statistical analysis for the 8-arm radial maze test was conducted using StatView (SAS Institute) and data were analyzed by two-way repeated measures ANOVA.
Correlations between variables were analyzed with Pearson's coefficient. Differences with a probability value of P<0.05 were considered to be statistically significant.
Supporting information
High adrenomedullin level in the circulating blood in AM-Tg mice
The plasma concentrations of human total AM were 355.2±44.5 fmol/mL in AM-Tg mice but not detected in WT mice. The physiological concentration of mouse total AM reportedly ranges from 5 to 20 fmol/mL. 19, 20 Therefore, the transgenic mice were expected to overproduce AM at about 50 times the magnitude of endogenous AM. The systolic BP (mmHg) was 116.1±7.5 in WT mice (n=16), 105.6±6.5 in AM-Tg mice (n=16), and 102±3.9 in hydralazine-treated WT (H-WT) mice (n=8).
There were no apparent differences in overall appearance, behavior, growth, or fertility between wild-type and AM-Tg mice. The body weight (g) at 10-12 weeks old before the operation was 27.4±1.9 in WT mice (n=16), 26.5±1.4 in AM-Tg mice (n=16), and 27.1±1.7 in
